• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡介苗接种对新冠病毒疫苗接种后抗体反应的影响。

The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination.

作者信息

Taks Esther J M, Moorlag Simone J C F M, Föhse Konstantin, Simonetti Elles, van der Gaast-de Jongh Christa E, van Werkhoven Cornelis H, Bonten Marc J M, Oever Jaap Ten, de Jonge Marien I, van de Wijgert Janneke H H M, Netea Mihai G

机构信息

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.

出版信息

iScience. 2023 Sep 28;26(11):108062. doi: 10.1016/j.isci.2023.108062. eCollection 2023 Nov 17.

DOI:10.1016/j.isci.2023.108062
PMID:37860692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10583058/
Abstract

Earlier studies showed that BCG vaccination improves antibody responses of subsequent vaccinations. Similarly, in older volunteers we found an increased IgG receptor-binding domain (RBD) concentration after SARS-CoV-2 infection if they were recently vaccinated with BCG. This study aims to assess the effect of BCG on the serum antibody concentrations induced by COVID-19 vaccination in a population of adults older than 60 years. Serum was collected from 1,555 participants of the BCG-CORONA-ELDERLY trial a year after BCG or placebo, and we analyzed the anti-SARS-CoV-2 antibody concentrations using a fluorescent-microsphere-based multiplex immunoassay. Individuals who received the full primary COVID-19 vaccination series before serum collection and did not test positive for SARS-CoV-2 between inclusion and serum collection were included in analyses (n = 945). We found that BCG vaccination before first COVID-19 vaccine (median 347 days [IQR 329-359]) did not significantly impact the IgG RBD concentration after COVID-19 vaccination in an older European population.

摘要

早期研究表明,卡介苗接种可改善后续疫苗接种的抗体反应。同样,在老年志愿者中,我们发现,如果他们最近接种了卡介苗,那么在感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)后,其免疫球蛋白G(IgG)受体结合域(RBD)浓度会升高。本研究旨在评估卡介苗对60岁以上成年人中由2019冠状病毒病(COVID-19)疫苗诱导的血清抗体浓度的影响。在接种卡介苗或安慰剂一年后,从卡介苗-冠状病毒-老年人试验的1555名参与者中采集血清,我们使用基于荧光微球的多重免疫测定法分析了抗SARS-CoV-2抗体浓度。分析纳入了在血清采集前接受了完整的COVID-19初级疫苗接种系列且在纳入研究至血清采集期间SARS-CoV-2检测未呈阳性的个体(n = 945)。我们发现,在首次接种COVID-19疫苗前(中位数347天[四分位距329 - 359])接种卡介苗,对老年欧洲人群接种COVID-19疫苗后的IgG RBD浓度没有显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/fd15858a1048/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/97005baf1d75/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/1d0bb9f703b8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/9127c108c8d5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/c0d97c2d8b1d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/fd15858a1048/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/97005baf1d75/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/1d0bb9f703b8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/9127c108c8d5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/c0d97c2d8b1d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26a1/10583058/fd15858a1048/gr4.jpg

相似文献

1
The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination.卡介苗接种对新冠病毒疫苗接种后抗体反应的影响。
iScience. 2023 Sep 28;26(11):108062. doi: 10.1016/j.isci.2023.108062. eCollection 2023 Nov 17.
2
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
3
BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial.医护人员接种卡介苗不会降低 SARS-CoV-2 感染率,也不会减轻感染严重程度或持续时间:一项随机安慰剂对照试验。
mBio. 2023 Apr 25;14(2):e0035623. doi: 10.1128/mbio.00356-23. Epub 2023 Mar 28.
4
BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.巴西医护人员的卡介苗再接种以改善针对新冠病毒的先天免疫反应:一项随机对照试验研究方案的结构化总结
Trials. 2020 Oct 26;21(1):881. doi: 10.1186/s13063-020-04822-0.
5
The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.昼夜节律对卡介苗接种预防 SARS-CoV-2 感染效果的影响。
Front Immunol. 2023 Feb 16;14:980711. doi: 10.3389/fimmu.2023.980711. eCollection 2023.
6
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.新型冠状病毒 ARCoV mRNA 疫苗在中国成年人中的安全性和免疫原性:一项随机、双盲、安慰剂对照、1 期临床试验。
Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24.
7
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals.接种疫苗人群中 SARS-CoV-2 病毒中和抗体滴度与刺突抗体和 ACE2 抑制的相关性。
Microbiol Spectr. 2022 Oct 26;10(5):e0131522. doi: 10.1128/spectrum.01315-22. Epub 2022 Sep 19.
8
Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.西弗吉尼亚州养老院队列中 COVID-19 疫苗接种后 SARS-CoV-2 抗体水平的持久性和保护潜力。
JAMA Netw Open. 2022 Sep 1;5(9):e2231334. doi: 10.1001/jamanetworkopen.2022.31334.
9
ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.ACTIVATE-2:一项针对 COVID-19 高危人群的卡介苗疫苗接种的双盲随机临床试验。
Front Immunol. 2022 Jul 5;13:873067. doi: 10.3389/fimmu.2022.873067. eCollection 2022.
10
Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic.BCG 疫苗对 2019 冠状病毒病大流行期间老年人呼吸道感染的疗效。
Clin Infect Dis. 2022 Aug 24;75(1):e938-e946. doi: 10.1093/cid/ciac182.

引用本文的文献

1
Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination.卡介苗接种对SARS-CoV-2免疫反应及新冠疫苗接种的影响。
Clin Transl Immunology. 2025 Jan 25;14(1):e70023. doi: 10.1002/cti2.70023. eCollection 2025.
2
BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial.医护人员接种卡介苗以预防 COVID-19:一项国际随机对照试验的 12 个月结果。
J Infect. 2024 Oct;89(4):106245. doi: 10.1016/j.jinf.2024.106245. Epub 2024 Aug 8.

本文引用的文献

1
Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial.卡介苗疫苗预防有合并症的老年人群 COVID-19 和其他呼吸道感染:一项随机对照试验。
Clin Microbiol Infect. 2023 Jun;29(6):781-788. doi: 10.1016/j.cmi.2023.01.019. Epub 2023 Feb 2.
2
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults.BCG 疫苗对 COVISHIELD™ 疫苗诱导 SARS-CoV-2 血清阴性印度年轻成年人免疫应答的异源获益证据。
Front Immunol. 2022 Oct 4;13:985938. doi: 10.3389/fimmu.2022.985938. eCollection 2022.
3
Beneficial non-specific effects of live vaccines against COVID-19 and other unrelated infections.
新冠病毒和其他不相关感染的活疫苗的有益非特异性效应。
Lancet Infect Dis. 2023 Jan;23(1):e34-e42. doi: 10.1016/S1473-3099(22)00498-4. Epub 2022 Aug 26.
4
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.卡介苗疫苗减少 COVID-19 大流行期间医护人员缺勤的随机对照试验。
Clin Microbiol Infect. 2022 Sep;28(9):1278-1285. doi: 10.1016/j.cmi.2022.04.009. Epub 2022 Apr 28.
5
Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic.BCG 疫苗对 2019 冠状病毒病大流行期间老年人呼吸道感染的疗效。
Clin Infect Dis. 2022 Aug 24;75(1):e938-e946. doi: 10.1093/cid/ciac182.
6
BCG vaccination provides protection against IAV but not SARS-CoV-2.BCG 疫苗接种可预防流感病毒但不能预防 SARS-CoV-2。
Cell Rep. 2022 Mar 8;38(10):110502. doi: 10.1016/j.celrep.2022.110502. Epub 2022 Feb 21.
7
Towards a population-based threshold of protection for COVID-19 vaccines.针对 COVID-19 疫苗的基于人群的保护阈值。
Vaccine. 2022 Jan 21;40(2):306-315. doi: 10.1016/j.vaccine.2021.12.006. Epub 2021 Dec 15.
8
Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19.为何女性表现更佳:COVID-19 中 X 染色体 TLR7 基因剂量效应。
Front Immunol. 2021 Nov 11;12:756262. doi: 10.3389/fimmu.2021.756262. eCollection 2021.
9
Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2.BCG 复种对 SARS-CoV-2 疫苗接种的职业暴露医务人员的影响。
Cells. 2021 Nov 15;10(11):3179. doi: 10.3390/cells10113179.
10
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.辉瑞-BioNTech 新冠疫苗接种 6 个月后免疫体液反应逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e84. doi: 10.1056/NEJMoa2114583. Epub 2021 Oct 6.